Constructing a Selection Biomarker Panel in the CardiAMP Autologous Cell Therapy Phase III HFrEF & Phase III Chronic Myocardial Ischemia Programs
Time: 3:00 pm
day: Conference Day 2
Details:
- Patient selection biomarker assessment for autologous cell therapy
- Considerations in the development and use of a biomarker panel
- Logistics of implementation
